Rémi Quirion, chief scientist of Québec and chairman of the board of directors of the Fonds de recherche du Québec – Santé (FRQS), has announced the appointments of Claude Lazure, Ph.D. as interim scientific director, effective early January 2012 and of Dr. Michel Bureau as an adviser to the FRQS, effective January 2012.

A researcher at the Institut de recherches cliniques de Montréal, Claude Lazure has been a scientific adviser to the Fonds’ research centre program for the past 10 years and is very familiar with the organization. He has also served on several of the Fonds’ evaluation committees.

Mr. Lazure’s appointment follows the departure of Viviane Poupon, who was the interim scientific director of the Fonds until today. Ms. Poupon has accepted a high-level administrative position at the Montréal Neurological Institute.

President and CEO of the Fonds from 1996 to 2003, Michel Bureau will bring his clinical research expertise to the organization, especially in matters pertaining to the Québec Biopharmaceutical Strategy and the development of clinical research in Québec in partnership with the Canadian Institutes of Health Research.

“I would like to thank Viviane Poupon for her hard work and express my gratitude to Claude Lazure, who will support the Fonds team during this transition period. I would also like to thank Michel Bureau for his future contributions to our clinical research and biopharmaceutical initiatives,” said Rémi Quirion.


For more info about the Fonds de recherche du Québec – Santé (FRQS)